Oronsky, Bryan <br/><br/>
RRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibition.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Aug 2019 
 - 2045-2050 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-019-02958-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Azetidines--pharmacology<br/>Caco-2 Cells<br/>Cell Line, Tumor<br/>Cytoprotection--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HCT116 Cells<br/>Humans<br/>NF-E2-Related Factor 2--genetics<br/>Neoplasms--genetics<br/>Nitro Compounds--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--genetics